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Abstract
 
Mismatch repair proteins participate in antibody class switch recombination, although their
roles are unknown. Previous nucleotide sequence analyses of switch recombination junctions
indicated that the roles of Msh2 and the MutL homologues, Mlh1 and Pms2, differ. We now
asked if Msh2 and Mlh1 function in the same pathway during switch recombination. Splenic B
cells from mice deficient in both these proteins were induced to undergo switching in culture.
The frequency of switching is reduced, similarly to that of B cells singly deficient in Msh2 or
Mlh1. However, the nucleotide sequences of the S
 
 
 
-S
 
 
 
3 junctions resemble junctions from
Mlh1- but not from Msh2-deficient cells, suggesting Mlh1 functions either independently of or
before Msh2. The substitution mutations within S regions that are known to accompany
switch recombination are increased in Msh2- and Mlh1 single-deficient cells and further in-
creased in the double-deficient cells, again suggesting these proteins function independently in
class switch recombination. The finding that MMR functions to reduce mutations in switch
regions is unexpected since MMR proteins have been shown to contribute to somatic hyper-
mutation of antibody variable region genes.
Key words: B cells • immunoglobulin isotypes • mismatch repair • switch region mutations • 
switch junctions
 
Introduction
 
Antibody class switching occurs in B cells after activation by
antigen and results in a switch from IgM and IgD isotype
expression to IgG, IgE, or IgA isotype expression, thereby
changing the antibody effector functions while maintaining
the identical antigen specificity. Isotype switching occurs by
an intrachromosomal deletional recombination within tan-
demly repeated switch (S) region sequences located up-
stream of each Ig heavy chain constant region gene.
Recombination occurs anywhere within each S region seg-
ment, which differ in sequence from each other and also
vary in length from 2 to 10 kb (for a review, see reference
1). Activation-induced cytidine deaminase (AID) is required
for class switch recombination (CSR) and for somatic hy-
permutation (SHM) of antibody variable region genes (2,
3). Recent data from Neuberger et al. (4, 5) indicate that
AID directly deaminates genomic DNA. A current model
for the role of AID in CSR is to deaminate dC residues in S
regions, which generates U:G mismatches and initiates base-
excision repair, resulting in single-strand DNA breaks (6).
Consistent with this model, mice found deficient in uracil
DNA glycosylase (UNG), which is the first enzyme in the
 
base excision repair pathway, have greatly impaired (
 
 
 
10-
fold reduced) CSR (5). One possible explanation for the
low levels of CSR remaining is that mismatch repair
(MMR) proteins, specifically Msh2 and Msh6, might recog-
nize the U:G mismatch created by AID and initiate MMR
by introducing DNA breaks. Fibroblasts transfected with an
AID expression plasmid can recombine plasmid switch re-
combination substrates, indicating that AID is the only B
cell–specific component essential for CSR (7).
After creation of DNA breaks, recombination of S
 
 
 
with downstream S regions appears to occur by nonhomol-
ogous end-joining (NHEJ), because S-S junctions often
occur at very short microhomologies (0 to 2 nts) between
the upstream and downstream S regions (8). Furthermore,
the KU protein complex, thought to be essential for
NHEJ, is required for CSR (9, 10). Interestingly, the ki-
nase activity of DNA-PKcs is not required for CSR, as
shown by examination of 
 
scid
 
 mice (11); however, when
the DNA-PKcs gene is deleted by gene targeting, CSR to
all isotypes except IgG1 is eliminated (12).
Examination of mice deficient in the mismatch repair
(MMR) proteins Msh2, Mlh1, and Pms2 has shown that
 
Address correspondence to J. Stavnezer, Department of Molecular Ge-
netics and Microbiology, and Program in Immunology and Virology,
University of Massachusetts Medical School, 55 Lake Ave. North,
Worcester, MA 01655-0122. Phone: 508-856-4100; Fax: 508-856-5920;
E-mail: janet.stavnezer@umassmed.edu T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
1378
 
Mlh1 Functions Independently of Msh2 in Isotype Switching
 
these proteins have roles in CSR (13–16). Splenic B cells
from mice deficient in Msh2, Mlh1, and Pms2 show two-
to fivefold reductions in CSR, compared with wild-type B
cells when stimulated in culture, and also show altered
switch recombination junctions. MMR proteins in eukary-
otes fall into two classes: (a) the MutS homologues (Msh1–
6), which recognize DNA mismatches, loops, and other
distortions, and (b) the MutL homologues (Pms2, Mlh1,
and Mlh3 in mammals), which bind to MutS homologues
bound to DNA and are thought to recruit endonuclease,
exonuclease, and helicase activities (17). In addition to roles
in post-replicative MMR, i.e., the correction of mutations
introduced during DNA replication, MMR proteins have
roles in homologous recombination during meiosis and in
double-strand break repair (18, 19).
Switch recombination junctions obtained from both
IgG- and IgA-expressing MMR-deficient B cells differ
from junctions from wild-type B cells, suggesting that
MMR proteins are directly involved in CSR (13, 14, 16).
Interestingly, the characteristics of S junctions from Msh2-
deficient B cells differ from those of Mlh1- and Pms2-defi-
cient cells. Junctions formed during switching from IgM to
IgG3 (S
 
 
 
-S
 
 
 
3 junctions) in Msh2-deficient B cells show
decreased lengths of the microhomology normally ob-
served at S junctions from wild-type cells and increased oc-
currence of small insertions at the junctions which do not
correspond to the sequences of either the S
 
 
 
 or S
 
 
 
3 re-
gions (16). In addition, the junctions are restricted to the
portion of the S
 
 
 
 region containing tandem consensus re-
peats, although CSR normally also occurs both 5
 
 
 
 and 3
 
 
 
 to
this segment (13). By contrast, about one-fourth of the
junctions from Mlh1- and Pms2-deficient B cells showed
increased lengths of microhomology in comparison to
wild-type junctions and no obvious restriction in location
of recombination sites (14, 16). These data indicate that the
role of Msh2 differs from the role of Mlh1 and Pms2 in
CSR. However, these data do not indicate whether Msh2
is acting in a different pathway from Mlh1 or Pms2.
In this study we investigated whether Msh2 and Mlh1
function in the same or in different pathways in CSR. We
reasoned that if they were to function in different path-
ways, splenic B cells deficient in both Msh2 and Mlh1
might show a greater deficiency in CSR than either mutant
alone. In addition, the nucleotide sequences of the S junc-
tions should indicate if the proteins function in the same or
different pathways. If the proteins function in the same
pathway, it seemed likely that the junction sequences
would resemble those from cells deficient in the protein
which acts earlier in the pathway, which presumably would
be Msh2.
 
Materials and Methods
 
Mice.
 
Mlh1-deficient mice were made by gene targeting and
were obtained from R.M. Liskay, Oregon Health Sciences Uni-
versity, Portland, OR (20). Msh2-deficient mice were obtained
from T. Mak, University of Toronto, Toronto, CA (21). Mice
heterozygous for Mlh1 were bred to Msh2-heterozygotes to ob-
 
tain mice heterozygous for both genes. These double heterozy-
gotes were bred to generate mice deficient in both Mlh1 and
Msh2, as well as wild-type and single-deficient 
 
mlh1
 
 
 
/
 
 
 
 and
 
msh2
 
 
 
/
 
 
 
 mice used as littermate controls. For the analysis of
switching in cultured B cells, all the cells were from littermates.
However, the sequence analysis of 
 
msh2/mlh1
 
 
 
/
 
 
 
 mice was initi-
ated after the analysis of the wild-type and single-deficient junc-
tions was completed, and thus these mice are from the same col-
ony but are not true littermates.
 
B Cell Isolation and Cultures.
 
Splenic B cells were isolated and
cultured as described (15, 16).
 
PCR Amplification of S
 
 
 
-S
 
 
 
3 Junctions and Germline S
 
 
 
 and S
 
 
 
3
Segments.
 
Genomic DNA was isolated as described (16). S
 
 
 
-
S
 
 
 
3 junctions were amplified from genomic DNA by PCR using
the Expand Long Template Taq and Pfu polymerase mix
(Roche) and the primers 
 
 
 
3-H3 (5
 
 
 
-AACAAGCTTGGCTTA-
ACCGAGATGAGCC-3
 
 
 
) and g3–2 (5
 
 
 
-TACCCTGACCCA-
GGAGCTGCATAAC-3
 
 
 
) (16) for sequences M-M-4–138. Dif-
ferent primers were used for sequences M-M 201–262, Smu1
(5
 
 
 
-TAGTAAGCGAGGCTCTAAAAAGCAT-3
 
 
 
, nts 5031–
5055 of MUSIGCD07; reference 13) and Sg3–4 (5
 
 
 
-TGTC-
CTATCTACTTGGTTCCTCT-3
 
 
 
, nts 2645–2667 of MUSI-
GANA). These primers are located 168 nts 5
 
 
 
 and 40 nts 3
 
 
 
 to the
first primer set. The germline S
 
 
 
3 and the germline S
 
 
 
 sequences
were determined previously for comparison to S
 
 
 
-S
 
 
 
3 junctions
from cells induced to switch to IgG3 (16). The mutation fre-
quency in the recombinant products was determined by sequenc-
ing the entire cloned PCR product. In most cases both S
 
 
 
 and
S
 
 
 
3 sequences from one clone could be compared with the germ-
line segments, but occasionally the presence of deletions pre-
vented comparison with one side or the other. The PCR error
frequency in our experiments was determined to be 8.3 
 
 
 
 10
 
 
 
4
 
(9 substitutions in 10799 nts) by sequencing independently ampli-
fied S
 
 
 
-
 
 
 
3 junctions from the plasmacytoma TIB114, using pro-
cedures identical to ones used for splenic B cell junctions.
TIB114, like other plasmacytomas does not have AID and does
not undergo SHM (22).
 
Cloning, Identification, and Sequence Analysis of PCR Products.
 
PCR products were cloned into the vector pGEM
 
®
 
-T Easy
(Promega) or into pCR4-TOPO (Invitrogen) using blue/white
screening for inserts. DNA was isolated from white colonies us-
ing QIAprep spin miniprep kit (QIAGEN). Clones containing
S
 
 
 
-S
 
 
 
3 junction inserts of varying sizes were chosen to optimize
the identification of unique junctions. Nucleotide sequencing
was performed by the University of Massachusetts Medical
School Nucleic Acids Facility, using an ABI 377 DNA sequencer
and Big Dyes. Sequences were aligned using the Clustal program
of MacVector 6.5.3. Alignments were generally obvious, although
in a few cases more than one alignment was possible due to the re-
petitive nature of the sequences and occasional internal deletions.
In these cases, alignments were optimized to reduce nucleotide
differences between the germline and recombinant sequences. For
statistical analysis, data were grouped according to the number of
nts of identity at each junction: 0, 1 and 2, 3 and 4, and 5 or more
and the Fisher-Freeman-Halton test was applied. Analysis of the
whole table found significant differences between strains in the
distribution of nts of junctional identity (P 
 
  
 
0.005).
 
Results
 
To examine the ability of 
 
msh2/mlh1
 
 
 
/
 
 
 
 B cells to un-
dergo CSR, splenic B cells were cultured with inducers ofT
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isotype-specific CSR for 4 d and then analyzed by FACS
 
®
 
for surface Ig expression. The wild-type mice and mice de-
ficient in Msh2, Mlh1, or both Msh2 and Mlh1 were tested
in the same experiment and were always littermates. Fig. 1
presents two examples of FACS data showing surface iso-
type expression of wild-type and MMR-deficient B cells
stimulated to switch to IgG2a and IgG1. Fig. 2 A presents
the average amount of switching to each isotype as a per-
centage of switching in WT cells. CSR to all of the isotypes
assayed was reduced in 
 
msh2/mlh1
 
 
 
/
 
 
 
 B cells to 22 to 45%
of WT, but the reduction was no more than was observed
in cells from 
 
msh2
 
 
 
/
 
 
 
 or 
 
mlh1
 
 
 
/
 
 
 
 single-deficient mice.
To ensure that the reduced switching was not due to
problems in cell proliferation or the cell cycle, we exam-
ined proliferation in B cells from the wild-type and 3
strains of MMR-deficient mice cultured to induce isotype-
specific CSR. Proliferation, assayed by 
 
3
 
H-thymidine in-
corporation on day 3 of culture, was identical in wild-type
and all MMR-deficient cells under all induction conditions
(Fig. 2 B). The cell cycle, assayed by propidium iodide in-
corporation, was also not altered in MMR-deficient B cells
induced with LPS and anti-
 
 
 
-dextran for 65 h (Fig. 2 C).
As S
 
 
 
-S
 
 
 
3 junctions from 
 
msh2
 
 
 
/
 
 
 
 B cells are strikingly
different from 
 
mlh1
 
 
 
/
 
 
 
 S
 
 
 
-S
 
 
 
3 junctions, we reasoned that
the nucleotide sequence of the junctions in 
 
msh2/mlh1
 
 
 
/
 
 
 
B cells would indicate whether these proteins are function-
ing together in CSR. Genomic DNA was prepared from
cells induced to switch to IgG3 with LPS and anti-
 
 
 
-dex-
tran for 4 d. S
 
 
 
-S
 
 
 
3 junctions were amplified by PCR,
cloned and sequenced (Fig. 3). We compared the lengths of
overlap, or identity, between the S
 
 
 
 and S
 
 
 
3 sequences
(boxed nucleotides) and found that junctions from 
 
msh2/
mlh1
 
 
 
/
 
 
 
 mice have significantly longer overlaps than those
from 
 
msh2
 
 
 
/
 
 
 
 mice (P 
 
  
 
0.034) and are similar but not
identical to those from 
 
mlh1
 
 
 
/
 
 
 
 mice (P 
 
  
 
0.173; refer-
ences 14 and 16). Like Mlh1-deficient cells, there are junc-
tions with extended microhomology (5–11 nts); however,
the frequency of junctions with extended microhomology
seems to be lower (Table I). It is clear that cells from 
 
msh2/
mlh1
 
 
 
/
 
 
 
 B cells have junctions that differ from 
 
msh2
 
 
 
/
 
 
 
 B
cells, and therefore that Mlh1 must have a role in CSR that
does not require Msh2.
 
Nucleotide Mutations in S Regions Are Increased in MMR-
deficient B Cells.
 
Frequent nucleotide substitutions are ob-
served in the S regions surrounding switch recombination
Figure 1. Class switching is similarly reduced in Mlh1- and Msh2-sin-
gle-deficient and double-deficient mice. Representative FACS® analysis
of splenic B cells induced as indicated for 4d, surface stained with anti-
IgM and anti-IgG2a or anti-IgG1 and analyzed by flow cytometry.
Figure 2. (A) In vitro class switching in splenic B cells from Mlh1- and
Msh2-single-deficient and double-deficient mice expressed as percent of
switching in B cells from wild-type littermates. Culture conditions for
each isotype have been described (reference 16), except for IgG2a which
was induced by treatment with LPS   interferon-  (10 U/ml). The aver-
age of three experiments is shown (except n   2 for Mlh1- IgG1, IgG2a,
IgG2b, and IgG3) and error bars represent the SEM. (B) DNA synthesis
measured by 3H-thymidine incorporation in 3d cultures with the same
inducers used in panel A. Bars show the average of triplicate cultures plus
2 SD, and are representative of two experiments. (C) Cell cycle analysis
by propidium iodide staining of cells induced with LPS and anti- -dex-
tran for 65 h. The markers estimate the percent of cells in G0/G1, S, and
G2/M (left to right) phases of cell cycle.T
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Figure 3. Nucleotide sequences surrounding the switch recombination junctions cloned from Mlh1/Msh2-double-deficient cells induced with LPS
and anti- -dextran. The sequences are of PCR products amplified from 13 independent cultures from two mice. Each cloned sequence (designated M-M)
is shown aligned with the sequence of germline S  (AF446347, upper sequence) and germline S 3, (lower sequence) from 129   C57BL/6 mice (16),
or occasionally from BALB/c mice (MUSIGCD09) as necessary. The boxed nucleotides represent the overlap in sequence between S  and S 3 with the
number of these nucleotides shown to the right of each sequence. A vertical line represents no overlap (no identity). Underlined, boldface nucleotides are
designated as insertions as these nucleotides do not appear to be templated by either S region.T
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junctions (8, 23). These mutations are interpreted as indi-
cating that error-prone DNA synthesis is involved in creat-
ing S-S junctions (23). The mutations are reminiscent of
those observed during Ig V gene SHM, which have been
shown to occur less frequently in mice deficient in Msh2,
Mlh1, or Pms2 (24, 25). We asked if MMR deficiency also
decreases mutation frequency in the cloned recombined
msh2/mlh1 /  S region segments in comparison to previ-
ously determined sequences from wild-type mice (16). We
found that MMR deficiency does indeed affect the muta-
tion frequency, but unlike V gene mutations introduced by
SHM, S region mutations are increased in MMR-deficient
B cells (Table II). These data suggest that MMR is involved
in removing mutations introduced into S regions, presum-
ably by AID and/or by the error-prone DNA synthesis
proposed to accompany CSR (4, 23, 26). Furthermore,
these data provide further evidence for the hypothesis that
Mlh1 can function independently of Msh2, as the fre-
quency of mutations is significantly higher in sequences
from the double-deficient cells than in WT cells, whereas
sequences from the single-deficient cells are not as highly
mutated. These data indicate that Mlh1, in the absence of
Msh2, can function in mutation repair within S regions.
The role of Mlh1 in the absence of Msh2 appears to affect
the sequences of the junctions and surrounding sequences
without further reducing the efficiency of class switching.
Discussion
We had hypothesized that a combined deficiency of Msh2
and Mlh1 would have the phenotype of Msh2-deficiency in
CSR, as binding of a Msh2 heterodimer with either Msh3 or
Msh6 to DNA is the first step in the postreplicative MMR
pathway, and as Msh2 functions in double-strand break re-
pair in yeast without the MutL homologues (27). Instead, we
found that a portion of the switch recombination junctions
from Msh2/Mlh1 double-deficient cells showed a pheno-
type similar to Mlh1- or Pms2 deficiency, i.e., increased
junctional microhomology relative to WT junctions, which
is significantly different from Msh2 deficiency. From these
data, we conclude that the presence of Mlh1/Pms2 het-
erodimers prevents the formation of switch junctions with
extended microhomologies, whether or not Msh2 is present.
Atomic force microscopy has shown that yeast Mlh1/
Pms1 can directly bind two different DNA molecules (28),
suggesting it might participate in synapsis of S region junc-
tions in the absence of Msh2 or other MutS homologues.
In addition, the NH2-terminal domain of human Pms2 can
bind DNA as a monomer (29). Perhaps the Mlh1/Pms2
heterodimer is involved in forming the synaptic structure
between the S  and S 3 sequences. In its absence, the in-
creased microhomology we observe at the junction may
provide stability to the structure. The Msh2 heterodimer
might function subsequently to process DNA ends before
ligation. Perhaps Msh2 excises single-strand ends that if
not removed result in mutations that resemble inserts at
the junction. It is notable that the lengths of microhomol-
ogy and presence of inserts in junctions from the msh2/
mlh1 /  cells seem somewhat intermediate between
msh2 /  and mlh1 /  junctions (Table I), suggesting that
Msh2 also has a function in the absence of Mlh1. Although
comparison of junctions from wild-type and msh2 /  cells
supports a role for Msh2 in end-processing, the msh2/
mlh1 /  junctions clearly show that Msh2 is not needed to
obtain extended microhomologies.
Table I. S -S 3 Junctions in msh2/mlh1 /  B Cells Differ from 
Junctions in msh2 /  Cells
Percentage of junctions with indicated
length of microhomology
Mouse  2 bp  5 bp  8 bp  10 bp
No. of
sequences
Percentage
w/inserts
WTa 44 3 0 0 32 3
Mlh1 /  49 30 17 11 47 2
Pms2 /  40 24 16 16 25 4
Msh2 /  19 0 0 0 32 19
Msh2b/
Mlh1 /  38 13 9 9 32 6
aSequences of WT, mlh1 / ,  pms2 / ,  msh2 /  junctions were re-
ported previously (reference 20), except for 24 additional sequences
from another mlh1 /  mouse from the same colony.
bDistribution of lengths of microhomology is significantly different
from msh2 / , P   0.034, but not from mlh1 / , P   0.173.
Table II. Mutations Are Increased in Recombined S  and S 3 
Segments from Mismatch Repair-deficient Cells
WT msh2 /  mlh1 /  msh2/mlh1 / 
S  mutation freq ( 104) 25.0 44.6 36.3 63.7
S  mutations 24 28 58 62
Nucleotides sequenced 9,598 6,278 15,976 9,730
Signif. of diff. from:a
WT 0.046 NS 0.0001
msh2 /  NS NS
mlh1 /  0.002
S 3 mutation freq ( 104) 19.2 34.3 26.9 44.9
S 3 mutations 18 23 43 45
Nucleotides sequenced 9,384 6,694 15,985 10,023
Signif. of diff. from:
WT NS NS 0.002
msh2 /  NS NS
mlh1 /  0.021
NS, not significant.
aBy Fisher’s exact test.T
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Alternatively, it is possible that Mlh1 may be functioning
with another MutS homologue, instead of directly binding
to DNA itself. Mlh1 is thought to function in meiosis with
Msh4 and 5, and Msh4 and Msh5 have been shown to bind
Holliday junctions and to be required for crossing over
during meiosis (18, 20, 30). However, the process of meio-
sis involves homologous recombination, which is not in-
volved in CSR, as different S regions do not share the re-
quired lengths of homology. In addition, the sites of
recombination used indicate that the repeat units do not
align in register (8). Whether Mlh1/Pms2 functions alone
or with other MutS homologues, our data suggest that it
directs switching to an end-joining type of pathway and
prevents an alternative short-homology pathway. This ac-
tivity clearly does not depend on Msh2.
The use of an alternate pathway may explain why class
switching in vitro is not further reduced in the Mlh1/
Msh2-deficient mice, relative to those deficient in Mlh1
or Msh2 alone, as the frequency of switching would be
governed by the rate of this alternate pathway. This alter-
nate pathway may also be used when the kinase Ataxia-
Telangectasia Mutated (ATM) is absent, since these switch
junctions have been shown to have increased lengths of
microhomology as well (31). Our data suggest that the
Mlh1/Pms2 heterodimer is involved during normal CSR,
perhaps to hold the DNA ends together in a particular
structure thus focusing recombination to the DNA ends,
but when this heterodimer is not available, an alternative
pathway can be used. Although DNA-PK has also been
proposed to focus recombination to DNA ends, the role
of Mlh1 differs, as mice deficient in DNA-PKcs do not
manifest increased lengths of microhomology at S -S 1
junctions (12).
Altogether the data support the model that during CSR,
the Mlh1/Pms2 heterodimer stabilizes and provides a struc-
ture to the synaptic complex, perhaps inhibiting the gener-
ation of relatively long stretches of junctional homology,
and focusing the recombination to the DNA ends. The
Mlh1/Pms2 heterodimer may function alone or with a
MutS heterodimer that does not include Msh2. The data
also suggest that Msh2 acts subsequently or independently
to recruit end-processing machinery that trims DNA ends,
resulting in S -S 3 junctions that normally manifest one to
two nucleotides of microhomology and infrequent appear-
ance of sequence insertions.
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